ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 42 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 66 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 66 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 66 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 66 | -41.1% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 112 | -99.6% | 0.00% | – |
| Q4 2017 | $121,000 | +1412.5% | 29,660 | +1487.8% | 0.00% | – |
| Q3 2017 | $8,000 | -96.4% | 1,868 | -97.2% | 0.00% | – |
| Q2 2017 | $222,000 | -48.6% | 66,661 | +42.1% | 0.00% | – |
| Q1 2017 | $432,000 | -37.8% | 46,899 | -47.9% | 0.00% | – |
| Q4 2016 | $694,000 | -54.9% | 89,978 | -33.1% | 0.00% | -100.0% |
| Q3 2016 | $1,538,000 | +22.6% | 134,595 | +32.0% | 0.00% | 0.0% |
| Q2 2016 | $1,254,000 | +6.7% | 101,933 | -13.3% | 0.00% | 0.0% |
| Q1 2016 | $1,175,000 | +362.6% | 117,537 | +916.3% | 0.00% | – |
| Q4 2015 | $254,000 | +74.0% | 11,565 | +27.0% | 0.00% | – |
| Q3 2015 | $146,000 | +1522.2% | 9,109 | +2143.6% | 0.00% | – |
| Q2 2015 | $9,000 | -81.2% | 406 | -78.7% | 0.00% | – |
| Q1 2015 | $48,000 | +60.0% | 1,910 | +33.6% | 0.00% | – |
| Q4 2014 | $30,000 | -42.3% | 1,430 | -51.1% | 0.00% | – |
| Q3 2014 | $52,000 | -68.5% | 2,924 | -59.1% | 0.00% | – |
| Q2 2014 | $165,000 | -2.4% | 7,149 | +39.1% | 0.00% | – |
| Q1 2014 | $169,000 | +4125.0% | 5,141 | +3445.5% | 0.00% | – |
| Q4 2013 | $4,000 | 0.0% | 145 | -45.3% | 0.00% | – |
| Q3 2013 | $4,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|